Micro-RNA decides malignancy of lung cancer
September 9th, 2010 - 5:25 pm ICT by ANIWashington, Sep 9 (ANI): Micro-RNA is what determines the malignancy of lung cancer, found a new study.
Professor Dr. Heike Allgayer, head of a Clinical Cooperation Unit of DKFZ and UMM, is an expert for those cellular processes that lead to metastasis in cancer.
In recent years, scientists have discovered that production of many proteins is regulated by what are called micro-RNAs.
These RNA molecules, which consist of only about 23 building blocks, attach specifically to messenger RNAs, which contain the blueprints for proteins. In this way, they block the production of the respective protein.
“We believe that micro-RNAs also play an important role in metastasis and that they program cells in a way that leads to malignant growth,” explained Heike Allgayer medical researcher.
In an international collaboration with researchers in Turin, Italy, Allgayer and her team used various cell lines of non-small cell lung cancer to investigate a particularly suspicious candidate called miR-200c and its role in malignant growth.
The research team found out that the less miR-200c is produced by a cell line, the higher its motility and its capacity to invade surrounding tissue.
When the researchers experimentally equipped the cancer cells with additional miR-200c, the amount of tissue-anchoring molecules on their surface increased and their invasive capacity became lower.
In animal experiments, these cells produced less metastasis.
A dreaded characteristic of non-small cell lung cancer is its resistance to chemotherapy and targeted anticancer drugs.
A lack of miR-200c also play a role here-therapy-resistant lung cancer cell lines that were experimentally equipped with miR-200c could subsequently be killed by the chemotherapy drug cisplatin and responded to cetuximab, a drug that block growth signals.
The researchers also discovered how the loss of miR-200c is brought about in cancer cells.
The researchers found that the lower the miR-200c level in the cancer cells, the more frequently metastasis had already begun.
“Our results clearly show a connection between a loss of miR-200c and transition to aggressive, invasive growth, metastasis and chemoresistance,” summarized Heike Allgayer. ANI)
- Key component in the spread of lung cancer discovered - Mar 15, 2011
- RNA-based drugs may prevent premature labour - Nov 16, 2010
- Scientists convert skin cells to stem cells more effieciently - Feb 03, 2011
- New discovery could shrink dengue-spreading mosquito population - Dec 03, 2010
- MicroRNAs could increase amputation risk in diabetics - Jan 13, 2011
- New discovery may help in the fight against ovarian cancer - Feb 04, 2011
- Lung cancer culprit could offer therapeutic target - Sep 14, 2010
- Key enzyme in melanoma cell development found - Jun 18, 2010
- Molecular pathway responsible for Parkinson's disease identified - Jul 29, 2010
- Scientists make breakthrough in small-cell lung cancer - Jan 14, 2010
- New discovery shows promise against pancreatic cancer - Dec 16, 2010
- Scientists discover cancer treatment in 'junk DNA' - Sep 29, 2010
- New targets for treatment of invasive breast cancer identified - Aug 20, 2009
- How ovarian cancer resists chemotherapy - Mar 03, 2011
- Key step in body's ability to make red blood cells found - Aug 01, 2010
Tags: animal experiments, anticancer drugs, cancer cell, cancer cells, cell lung cancer, cellular processes, cetuximab, chemotherapy drug cisplatin, cisplatin, dkfz, international collaboration, lung cancer, malignancy, malignant growth, medical researcher, messenger rnas, non small cell lung cancer, rna molecules, small cell lung cancer, turin italy